About EndoSound
EndoSound is a private company based in Portland, Oregon. It has reported $4,969,565 raised in five offerings on Form D since March 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Jun 17, 2026 | $250,000of $5.0M target | 1 | $250K | EquityRule 506(b) | Form D ↗ |
| Feb 9, 2024 | Feb 12, 2024amended Aug 11, 2025 | $1,944,748of $5.0M target | 10 | $194K | DebtRule 506(c) | Form D/A ↗1 earlier filing |
| Apr 26, 2023 | May 2, 2023 | $2,364,000of $5.3M target | 17 | $139K | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 29, 2022 | Mar 30, 2022 | $50,000of $1.5M target | 1 | $50,000 | DebtRule 506(b) | Form D ↗ |
| Mar 3, 2021 | Mar 12, 2021 | $360,817of $1.9M target | 4 | $90,204 | EquityRule 506(b) | Form D ↗ |
| Total, five offerings | $4,969,565 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on EndoSound's Form D filed Jun 17, 2026.
Earlier filings also listed William Rhodes (director, last listed Aug 2025) and Brian Tinkham (director, last listed Aug 2025).